MTD Group enhances global reach with acquisition of Ypsomed’s pen needles and blood glucose monitoring systems
Medical Technology and Devices (MTD) has announced the successful completion of its acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses. This strategic move, first revealed in March, represents a significant advancement in MTD’s mission to deliver superior solutions in diabetes and obesity care on a global scale. Strategic Acquisition Bolsters Market […]
